BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 10493259)

  • 1. The CYP2A subfamily: function, expression and genetic polymorphism.
    Raunio H; Rautio A; Pelkonen O
    IARC Sci Publ; 1999; (148):197-207. PubMed ID: 10493259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2A6: genetics, structure, regulation, and function.
    Raunio H; Rahnasto-Rilla M
    Drug Metabol Drug Interact; 2012 May; 27(2):73-88. PubMed ID: 22706231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CYP2A genes in rodent and human nasal mucosa.
    Su T; Sheng JJ; Lipinskas TW; Ding X
    Drug Metab Dispos; 1996 Aug; 24(8):884-90. PubMed ID: 8869824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.
    Fernandez-Salguero P; Hoffman SM; Cholerton S; Mohrenweiser H; Raunio H; Rautio A; Pelkonen O; Huang JD; Evans WE; Idle JR
    Am J Hum Genet; 1995 Sep; 57(3):651-60. PubMed ID: 7668294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CYP2A genes in human liver and extrahepatic tissues.
    Koskela S; Hakkola J; Hukkanen J; Pelkonen O; Sorri M; Saranen A; Anttila S; Fernandez-Salguero P; Gonzalez F; Raunio H
    Biochem Pharmacol; 1999 Jun; 57(12):1407-13. PubMed ID: 10353262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homologous unequal cross-over within the human CYP2A gene cluster as a mechanism for the deletion of the entire CYP2A6 gene associated with the poor metabolizer phenotype.
    Nunoya K; Yokoi T; Takahashi Y; Kimura K; Kinoshita M; Kamataki T
    J Biochem; 1999 Aug; 126(2):402-7. PubMed ID: 10423536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis.
    Fernandez-Salguero P; Gonzalez FJ
    Pharmacogenetics; 1995; 5 Spec No():S123-8. PubMed ID: 7581481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Tobacco Smoke/Nicotine on CYP2A Expression in Human and African Green Monkey Lungs.
    Gao Y; Miksys S; Palmour RM; Tyndale RF
    Mol Pharmacol; 2020 Dec; 98(6):658-668. PubMed ID: 33055223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of CYP2A6 and its practical consequences.
    Raunio H; Rautio A; Gullstén H; Pelkonen O
    Br J Clin Pharmacol; 2001 Oct; 52(4):357-63. PubMed ID: 11678779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 CYP2D6.
    Wolf CR; Smith G
    IARC Sci Publ; 1999; (148):209-29. PubMed ID: 10493260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the cytochrome P450 2A genes.
    Su T; Ding X
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):285-94. PubMed ID: 15364544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2A6 polymorphisms in Malays, Chinese and Indians.
    Nurfadhlina M; Foong K; Teh LK; Tan SC; Mohd Zaki S; Ismail R
    Xenobiotica; 2006 Aug; 36(8):684-92. PubMed ID: 16891249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation enzyme polymorphism and pesticide susceptibility.
    Eaton DL
    Neurotoxicology; 2000; 21(1-2):101-11. PubMed ID: 10794390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oxidative phenotype as a marker of individual predisposition to neoplasm induced by chemical carcinogens.
    Lutz W; Sułkowski W
    Pol J Occup Med; 1990; 3(3):257-72. PubMed ID: 2136533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients?
    Farinola N; Piller NB
    Pharmacogenomics; 2007 Feb; 8(2):151-8. PubMed ID: 17286538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomics of smoking exposure and cessation: lessons for cancer prevention and treatment.
    Penning TM; Lerman C
    Cancer Prev Res (Phila); 2008 Jul; 1(2):80-3. PubMed ID: 19138939
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenetic phenotyping and genotyping. Present status and future potential.
    Gonzalez FJ; Idle JR
    Clin Pharmacokinet; 1994 Jan; 26(1):59-70. PubMed ID: 8137598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-individual Variability of Coumarin 7-hydroxylation (CYP2A6 activity) in an Iranian Population.
    Hassanzadeh Khayyat M; Vahdati Mashhadian N; Eghbal S; Jalali N
    Iran J Basic Med Sci; 2013 Apr; 16(4):610-4. PubMed ID: 24250937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-silico structural, virtual screening and docking studies of Human Cytochrome P450 2A7 protein.
    Lodhi SS; Farmer R; Jaiswal YK; Wadhwa G
    Interdiscip Sci; 2014 Nov; ():. PubMed ID: 25519152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.